Clinical Trials on Embryonal Childhood Rhabdomyosarcoma in Australia
Total 629 results
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedJuvenile Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Childhood Acute Lymphoblastic Leukemia | Prolymphocytic Leukemia | Hairy Cell Leukemia | Acute Undifferentiated Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Childhood Acute Myeloid... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand
-
ImmVira Pharma Co. LtdRecruitingMelanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell CarcinomaUnited States, Australia
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States, Canada, Australia, Switzerland
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Australia
-
IpsenCompletedAcromegaly | Neuroendocrine TumoursSwitzerland, Austria, Germany
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Medical University of ViennaRecruiting
-
Medical University of GrazCompletedMelanoma | Skin Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Squamous Cell CarcinomaAustria
-
Nativis, Inc.CompletedGlioblastoma MultiformeUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingMalignant Germ Cell Tumor | Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Extragonadal Embryonal Carcinoma | Malignant Ovarian Teratoma | Stage I Ovarian Choriocarcinoma | Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 | Stage I Ovarian Teratoma AJCC v6 and v7 | Stage I Ovarian Yolk... and other conditionsUnited States, Canada, Japan, Australia, Puerto Rico, New Zealand, Saudi Arabia, United Kingdom, India
-
Christoph ArnoldnerRecruiting
-
Christoph ArnoldnerRecruitingHearing Loss | Vestibular SchwannomaAustria
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
European Organisation for Research and Treatment...Tragara Pharmaceuticals, Inc.CompletedGlioblastoma | Astrocytoma, Grade IIIFrance, Austria, Germany, Netherlands, Switzerland
-
Bristol-Myers SquibbWithdrawnMelanomaFrance, Italy, Poland, United States, Brazil, Spain, Australia, Denmark, Germany, Austria, Netherlands, Russian Federation, Belgium, United Kingdom, Sweden, Switzerland
-
European Organisation for Research and Treatment...RecruitingFirst Progression of GlioblastomaNetherlands, Austria, Germany
-
PlexxikonRoche Pharma AGCompletedColorectal Carcinoma | Malignant MelanomaUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Neuroendocrine Neoplasm | Myeloproliferative Neoplasm | Desmoid Fibromatosis | Lymphoproliferative Disorder | Carcinoma In Situ | Central Nervous System Neoplasm | Ganglioneuroma | Congenital Mesoblastic Nephroma | Childhood Immature Teratoma | Childhood Langerhans Cell Histiocytosis and other conditionsUnited States, Puerto Rico, Canada, Australia, New Zealand, Saudi Arabia
-
AmgenCompletedGlioblastoma or Malignant GliomaUnited States, Australia, Netherlands, Germany, Spain, France
-
National Cancer Institute (NCI)RecruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada
-
Histiocyte SocietyCompletedChildhood Langerhans Cell HistiocytosisCanada, United Kingdom, United States, France, Germany, Austria, Ireland, Sweden, Italy, Argentina
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Genentech, Inc.BioNTech SEActive, not recruitingAdvanced MelanomaUnited States, Spain, Belgium, Australia, Germany, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Active, not recruitingNeuroblastomaCanada, United States, Australia
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Medical University InnsbruckPfizerUnknownGlioblastoma MultiformeAustria, Germany
-
Grupo Espanol de Tumores NeuroendocrinosEisai Limited; Experior S.L.CompletedNeuroendocrine TumorsSpain, Italy, Austria, United Kingdom
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); University of Florida; The Pew Charitable TrustsActive, not recruitingBrain and Central Nervous System TumorsUnited States, Australia
-
Xenova BiomedixWithdrawnGlioblastoma MultiformeUnited States, Australia
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
St. Olavs HospitalOdense University Hospital; Karolinska University Hospital; Turku University... and other collaboratorsRecruiting
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
Arcispedale Santa Maria Nuova-IRCCSCompletedNeuroendocrine TumoursAustria, Italy
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbTerminatedMetastatic MelanomaUnited States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
-
Columbia UniversityRecruitingUveal MelanomaUnited States, Australia, Canada, Germany, United Kingdom
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Karsten GavenisRecruitingNeuroendocrine Tumors | Neuroendocrine CarcinomaGermany, Austria